We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+10.47%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$2.94B
AUM Growth
+$184M
Cap. Flow
-$79.5M
Cap. Flow %
-2.7%
Top 10 Hldgs %
42.7%
Holding
135
New
34
Increased
27
Reduced
33
Closed
29

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$53.9M
2
ORLY icon
O'Reilly Automotive
ORLY
+$41M
3
BIIB icon
Biogen
BIIB
+$40.8M
4
ENTA icon
Enanta Pharmaceuticals
ENTA
+$36.6M
5
ULTA icon
Ulta Beauty
ULTA
+$35M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$57.2M
2
MRK icon
Merck
MRK
+$43.5M
3
WSM icon
Williams-Sonoma
WSM
+$40.2M
4
AMAG
AMAG Pharmaceuticals
AMAG
+$38.7M
5
LOW icon
Lowe's Companies
LOW
+$34.2M

Sector Composition

Rank Sector Weight
1 Healthcare 48.15%
2 Consumer Staples 11.86%
3 Consumer Discretionary 11.13%
4 Technology 1.98%
5 Industrials 1.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
POST icon
51
Post Holdings
POST
$4.11B
$17.8M 0.6%
+268,928
New +$16.6M
VTRS icon
52
Viatris
VTRS
$20.6B
$17.5M 0.6%
936,000
-192,000
-17% -$3.13M
EGRX
53
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$17M 0.58%
364,000
-308,000
-46% -$14.4M
AMZN icon
54
Amazon
AMZN
$2.94T
$16.6M 0.56%
102,000
-96,460
-49% -$15.4M
ASMB icon
55
Assembly Biosciences
ASMB
$526M
$15.9M 0.54%
218,667
+154,667
+242% +$18.1M
AVTR icon
56
Avantor
AVTR
$9.04B
$15.4M 0.52%
548,000
-64,000
-10% -$1.65M
KHC icon
57
Kraft Heinz
KHC
$30.5B
$13.9M 0.47%
400,000
-600,000
-60% -$19.5M
MSFT icon
58
Microsoft
MSFT
$3.62T
$12.9M 0.44%
58,000
+26,000
+81% +$5.59M
AXNX
59
DELISTED
Axonics, Inc. Common Stock
AXNX
$12.4M 0.42%
248,000
+108,000
+77% +$5.07M
CLX icon
60
Clorox
CLX
$12.8B
$12.1M 0.41%
+60,000
New +$12.4M
PG icon
61
Procter & Gamble
PG
$341B
$12.1M 0.41%
+87,000
New +$12.2M
FREE
62
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$12.1M 0.41%
1,108,000
+284,000
+34% +$2.6M
ADMS
63
DELISTED
Adamas Pharmaceuticals
ADMS
$11.9M 0.4%
2,742,000
– –
EPC icon
64
Edgewell Personal Care
EPC
$1.35B
$11.6M 0.4%
336,000
-742,000
-69% -$24.1M
NTRA icon
65
Natera
NTRA
$39.4B
$11.5M 0.39%
+116,000
New +$9.69M
LIVN icon
66
LivaNova
LIVN
$4.29B
$11.4M 0.39%
172,000
+122,000
+244% +$6.78M
CRSP icon
67
CRISPR Therapeutics
CRSP
$5.07B
$11M 0.37%
72,000
-132,000
-65% -$15.6M
CLVS
68
DELISTED
Clovis Oncology, Inc.
CLVS
$10.8M 0.37%
2,256,000
+408,000
+22% +$2.06M
SIBN icon
69
SI-BONE Inc
SIBN
$809M
$9.69M 0.33%
324,000
+68,000
+27% +$1.66M
UBER icon
70
Uber
UBER
$139B
$9.18M 0.31%
180,000
+30,000
+20% +$1.34M
KPRX icon
71
Kiora Pharmaceuticals
KPRX
$11.3M
$8.95M 0.3%
5,043
– –
AYTU icon
72
AYTU BioPharma
AYTU
$24.7M
$7.97M 0.27%
+66,667
New +$12.1M
WDAY icon
73
Workday
WDAY
$42.1B
$7.19M 0.24%
+30,000
New +$6.74M
AVNS
74
DELISTED
Avanos Medical
AVNS
$7.16M 0.24%
156,000
-41,000
-21% -$1.71M
PRTS icon
75
CarParts.com
PRTS
$44.9M
$6.82M 0.23%
+55,000
New +$7.1M
1 2
3
4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2020 Portfolio in Review

As of Q4 2020, Armistice Capital held 135 positions worth $2.94B, up 6.7% from $2.76B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Armistice Capital's Q4 2020 filing shows 34 new, 27 increased, 33 reduced and 29 closed positions. Its largest new stake was Walmart Inc: 1,110,675 shares worth $53.4M. The largest sale was Alexion Pharmaceuticals, an estimated $57.2M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 48% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

  • Armistice Capital's largest Q4 2020 buy was Walmart Inc: 1,110,675 shares worth $53.4M.
  • Armistice Capital added most to Biogen in Q4 2020, an estimated $40.8M increase.
  • Armistice Capital's biggest Q4 2020 reduction was Energizer, cutting an estimated $29.6M.
  • Armistice Capital fully exited Alexion Pharmaceuticals in Q4 2020, selling an estimated $57.2M.
  • Armistice Capital's ten largest holdings make up 43% of its $2.94B portfolio in Q4 2020.
  • Armistice Capital opened 34 new positions and closed 29 in Q4 2020.
  • Armistice Capital's portfolio value rose 6.7% quarter-over-quarter to $2.94B.

Based on Armistice Capital's 13F filing for Q4 2020, filed 16 Feb 2021.